Agree with this question. The appropriate way to run the studies for the FDA would be to include data from the generic and the branded Lovenox. Comparing it to historical data submitted by SNY doesn't seem like the FDA way of doing things, unfortunately for PPHM.
Market Data 
Markets 
AI
